Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential-Reference-Cited by-同舟云学术

Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential

Published:2019-04 Issue:11 Volume:125 Page:1789-1798
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Varughese Rahel Sarah¹²,Lam Walter Sze‐Tung¹²,Marican Ahmad Abdurrahman bin Hanifah¹²,Viganeshwari S. Hema¹²,Bhave Anuja Satish¹²,Syn Nicholas L.¹²,Wang Jigang¹,Wong Andrea Li‐Ann¹³,Kumar Alan Prem¹²,Lobie Peter E.¹⁴,Lee Soo Chin¹³,Sethi Gautam²^ORCID,Goh Boon Cher¹²³⁵,Wang Lingzhi¹²

Affiliation:

1. Cancer Science Institute of Singapore National University of Singapore Singapore

2. Department of Pharmacology National University Health System Singapore

3. Department of Haematology‐Oncology National University Health System Singapore

4. Tsinghua Berkeley Shenzhen Institute Tsinghua University Shenzhen China

5. Department of Medicine National University Health System Singapore

Funder

National Research Foundation Singapore

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32069

Reference66 articles.

1. Cancer statistics, 2018

2. Paclitaxel

3. How Taxol/paclitaxel kills cancer cells

4. Multicenter Phase II Trial of Weekly Paclitaxel in Women With Metastatic Breast Cancer

5. Paclitaxel: a new antineoplastic agent for refractory ovarian cancer;Gregory RE;Clin Pharm,1993

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule inhibitors targeting heat shock protein 90: An updated review;European Journal of Medicinal Chemistry;2024-09

2. Enantioselective Reduction and Sulfenylation of Isoflavanone Derivatives via Bisguanidinium Hypervalent Silicate;Organic Letters;2024-07-12

3. Recent advances in flavonoid compounds for the treatment of prostate cancer;Molecular Biology Reports;2024-05-11

4. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway;Cancer Management and Research;2024-05

5. Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis;Cell Death & Disease;2024-01-31